Key result
Shipi Shugan Decoction dose-dependently inhibited inflammatory factors, mitochondrial dysfunction, and oxidative stress, and improved pathological injury in SPID rats via the SIRT1/NLRP3 pathway.
Why the study?
Sequela of pelvic inflammatory disease is clinically common, and this study aimed to investigate the protective mechanism of Shipi Shugan Decoction using a rat model.
Does Shipi Shugan Decoction protect against sequela of pelvic inflammatory disease in a rat model?
Does Shipi Shugan Decoction protect against sequela of pelvic inflammatory disease in a rat model?
Shipi Shugan Decoction protects against sequela of pelvic inflammatory disease in rats by inhibiting the SIRT1/NLRP3 signaling pathway.
Answers are grounded in this paper and cite their sources.
Hypothesis-generating for Shipi Shugan Decoction in SPID sequelae; clinical translation untested and should not alter practice.
Sequela of pelvic inflammatory disease (SPID) is a common and frequently occurring disease clinically. Traditional Chinese medicine (TCM) provided unique advantages in the treatment of SPID. In this study, we aimed to investigate the protective mechanism of Shipi Shugan Decoction (SSD), a Chinese herbal formula, on SPID using a SPID rat model. Mixed bacterial infection and mechanical injury were used for modeling. The chemical composition of SSD was analyzed by ultra-performance liquid chromatography-mass spectrometry (UPLC-MS). The inflammatory factors were detected by enzyme-linked immunosorbent assay (ELISA) and western blot techniques. We found that SSD dose-dependently inhibited the content of IL-18, IL-1β, TNF-α, and IL-6 in serum samples of SPID rats. The results from the hematoxylin and eosin (H&E) stain showed that SSD improved pathological injury of the uterus and fallopian tubes induced by a pathogen. In addition, SSD dose-dependently inhibited mitochondrial dysfunction and oxidative stress of SPID rats. The expression of SIRT1 was promoted, and NLRP3 inflammasome was deactivated by SSD gavage compared with the SPID group. Specifically, SIRT1 inhibitor EX-527 cotreatment significantly reversed the improvement effect of SSD on pelvic inflammatory disease in rats. Taken together, the results of this study suggest that Shipi Shugan Decoction may be an effective TCM for the treatment of SPID.
No takes yet. Share an insight, caveat, or question.
Wang et al. (2022) studied Sequela of pelvic inflammatory disease (SPID). Shipi Shugan Decoction (SSD) vs. SPID group was evaluated on Inflammatory factors, pathological injury, mitochondrial dysfunction, and oxidative stress. Shipi Shugan Decoction dose-dependently inhibited inflammatory factors, mitochondrial dysfunction, and oxidative stress, and improved pathological injury in SPID rats via the SIRT1/NLRP3 pathway.
Synapse has enriched 10 related papers. Consider them for comparative context: